BD-5

• Description:

  Defensins (alpha and beta) are cationic peptides with a broad spectrum of antimicrobial activity that comprise an important arm of the innate immune system. The alpha-defensins are distinguished from the beta-defensins by the pairing of their three disulfide bonds. To date, six human beta-defensins have been identified; BD-1, BD-2, BD-3, BD-4, BD-5 and BD-6. beta-defensins are expressed on some leukocytes and at epithelial surfaces. In addition to their direct antimicrobial activities, they can act as chemoattractants towards immature dendritic cells and memory T cells. The beta-defensin proteins are expressed as the C-terminal portion of precursors, and are released by proteolytic cleavage of a signal sequence and, in some cases, a propeptide sequence. Beta-defensins contain a six-cysteine motif that forms three intra-molecular disulfide bonds. Recombinant Human BD-5 is a 5.8 kDa protein containing 51 amino acid residues.

• Synonyms:

  BD5, DEFB5, DEFB105a, Beta-Defensin 5

• NCBI Gene ID:

  245908

• UniProt:

  Q8NG35

• Accession Number:

  NP_689463.1

• Accession Number mRNA:

  NM_152250.2

• Reactivity:

  Human

• Cross Reactivity:

  Human

• Sequence:

  GLDFSQPFPS GEFAVCESCK LGRGKCRKEC LENEKPDGNC RLNFLCCRQR I

• Endotoxin:

  < 0.1 ng/µg of protein (< 1EU/µg)

• Purity:

  > 98% by SDS-PAGE & HPLC analyses

• Bioactivity:

  Not available.

• Length:

  51

• Form:

  Lyophilized

• Molecular Weight:

  5,8 kDa

• Host or Source:

  E. coli